المؤلفون: Danique Giesen, E. L. van der Veen, J.B.A.G. Haanen, A. J. van der Wekken, Derk Jan A. de Groot, Lucie Hijmering-Kappelle, Mathilde Jalving, P P van de Donk, H.J.M. Groen, M. N. Lub-de Hooge, Adrienne H. Brouwers, E.G.E. de Vries, Wim Timens, Iris C. Kok, B. van der Hiel, W Uyterlinde, Sjoerd G. Elias, G.A.P. (Geke) Hospers, J A Hooiveld, Thijo J N Hiltermann

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), ​Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Translational Immunology Groningen (TRIGR), Groningen Research Institute for Asthma and COPD (GRIAC), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON)

المصدر: Annals of Oncology, 33(1), 80-88. Oxford University Press
Annals of Oncology

مصطلحات موضوعية: EXPRESSION, Oncology, medicine.medical_specialty, Biodistribution, PET/CT, medicine.medical_treatment, Standardized uptake value, Pembrolizumab, Internal medicine, PD-1, medicine, HETEROGENEITY, biology, medicine.diagnostic_test, business.industry, Melanoma, Cancer, Hematology, Immunotherapy, medicine.disease, PET, ANTIBODY, Positron emission tomography, SURVIVAL, biology.protein, pembrolizumab, immunotherapy, Zr-89, Antibody, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::781376a45d3e69e26c46f1276c3106dcTest
https://doi.org/10.1016/j.annonc.2021.10.213Test

المؤلفون: Arjen J. Witkamp, Joost Nederend, Andreas J A Bremers, Philip R. de Reuver, Wilhelmina M U van Grevenstein, Henk M.W. Verheul, Koen P. Rovers, Max J. Lahaye, Niels F. M. Kok, Jurriaan B. Tuynman, Checca Bakkers, Maartje Los, Ignace H. J. T. de Hingh, Anna M.J. Thijs, Patrick H. J. Hemmer, Alexandra R. M. Brandt-Kerkhof, Miriam Koopman, Onno Kranenburg, Petur Snaebjornsson, Marcel G. W. Dijkgraaf, Simon W. Nienhuijs, Arend G. J. Aalbers, Schelto Kruijff, Jacobus W. A. Burger, Tineke E. Buffart, Derk Jan A. de Groot, Esther van Meerten, Iris van 't Erve, Geert-Jan Creemers, Miranda Kusters, Pieter J. Tanis, Eva V. E. Madsen, Remond J.A. Fijneman, Kathelijn S. Versteeg, Djamila Boerma, Cornelis J A Punt, Marinus J. Wiezer

المساهمون: Surgery, CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Internal medicine, VU University medical center, Epidemiology and Data Science, APH - Methodology, Oncology, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Epidemiologie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: Rovers, K P, Bakkers, C, Nienhuijs, S W, Burger, J W A, Creemers, G-J M, Thijs, A M J, Brandt-Kerkhof, A R M, Madsen, E V E, van Meerten, E, Tuynman, J B, Kusters, M, Versteeg, K S, Aalbers, A G J, Kok, N F M, Buffart, T E, Wiezer, M J, Boerma, D, Los, M, de Reuver, P R, Bremers, A J A, Verheul, H M W, Kruijff, S, de Groot, D J A, Witkamp, A J, van Grevenstein, W M U, Koopman, M, Nederend, J, Lahaye, M J, Kranenburg, O, Fijneman, R J A, van 't Erve, I, Snaebjornsson, P, Hemmer, P H J, Dijkgraaf, M G W, Punt, C J A, Tanis, P J & de Hingh, I H J T 2021, ' Perioperative systemic therapy vs cytoreductive surgery and hyperthermic intraperitoneal chemotherapy alone for resectable colorectal peritoneal metastases: A phase 2 randomized clinical trial ', JAMA Surgery, vol. 156, no. 8, pp. 710-720 . https://doi.org/10.1001/jamasurg.2021.1642Test
JAMA Surgery, 156(8), 710-720. American Medical Association
JAMA surgery, 156(8), 710-720. American Medical Association
JAMA Surgery, 156(8), 710-720. AMER MEDICAL ASSOC
JAMA Surgery, 156, 710-720
JAMA Surg
JAMA Surgery, 156, 8, pp. 710-720

مصطلحات موضوعية: Male, PROGNOSIS, medicine.medical_treatment, CARCINOMATOSIS, MULTICENTER, Hyperthermic Intraperitoneal Chemotherapy, 030230 surgery, Peritoneal Neoplasms/secondary, law.invention, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], NEOADJUVANT CHEMOTHERAPY, 0302 clinical medicine, FOLFOX, Randomized controlled trial, law, Adenocarcinoma/secondary, Adjuvant/adverse effects, Neoadjuvant therapy, Original Investigation, Bevacizumab/administration & dosage, Cytoreduction Surgical Procedures, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, OPEN-LABEL, CANCER, Neoadjuvant Therapy, Fluorouracil/administration & dosage, Capecitabine/administration & dosage, 030220 oncology & carcinogenesis, FOLFIRI, Leucovorin/administration & dosage, Hyperthermic intraperitoneal chemotherapy, Female, medicine.drug, medicine.medical_specialty, Camptothecin/administration & dosage, Capecitabine, 03 medical and health sciences, Chemotherapy, Adjuvant/adverse effects, Oxaliplatin/administration & dosage, REGRESSION, medicine, MANAGEMENT, Chemotherapy, Humans, Organoplatinum Compounds/administration & dosage, Perioperative Period, Response Evaluation Criteria in Solid Tumors, Aged, Colorectal Neoplasms/pathology, HIPEC, business.industry, Perioperative, Surgery, Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10], Irinotecan, Mitomycin/administration & dosage, Feasibility Studies, business, CONSENSUS

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::375b682e7bd1c0c6ebfa96df3e48e33eTest
https://hdl.handle.net/11370/c9e531bb-9f62-460d-afc2-636baf20eec6Test

المؤلفون: Elisabeth G.E. de Vries, Marjolijn N. Lub-de Hooge, Anthonie J. van der Wekken, Sjoukje F. Oosting, Derk Jan A. de Groot, Adrienne H. Brouwers, Rudolf S N Fehrmann, Pim P. van de Donk, Laura Kist de Ruijter

المصدر: Theranostics

مصطلحات موضوعية: 0301 basic medicine, T cell, medicine.medical_treatment, T-Lymphocytes, Cell, Medicine (miscellaneous), immune checkpoint inhibitor, CANCER-PATIENTS, Review, METABOLIC-ACTIVITY, positron emitting tomography, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Immune system, Neoplasms, Biomarkers, Tumor, BREAST-CANCER, Medicine, Humans, REGULATORY T-CELLS, Pharmacology, Toxicology and Pharmaceutics (miscellaneous), Immune Checkpoint Inhibitors, Tomography, Emission-Computed, Single-Photon, medicine.diagnostic_test, LIGAND 1 EXPRESSION, business.industry, Patient Selection, biomarkers, Immunotherapy, medicine.disease, molecular imaging, F-18-FDG PET/CT, RESPONSE EVALUATION, immunotherapy, METASTATIC MELANOMA PATIENTS, PD-L1 EXPRESSION, 030104 developmental biology, medicine.anatomical_structure, Positron emission tomography, 030220 oncology & carcinogenesis, Positron-Emission Tomography, TUMOR RESPONSE, Cancer research, Molecular imaging, business, Emission computed tomography

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b0c07e0bd89c9efeb7bee8236f96660Test
http://europepmc.org/articles/PMC6993216Test

المؤلفون: Elisabeth G.E. de Vries, Marjolijn N. Lub-de Hooge, Frans V. Suurs, Derk Jan A. de Groot

المصدر: Pharmacology & Therapeutics. 201:103-119

مصطلحات موضوعية: Bispecific antibody (bsAb), 0301 basic medicine, Oncology, medicine.medical_specialty, Bispecific antibody, MEDULLARY-THYROID CARCINOMA, medicine.drug_class, ANTITUMOR-ACTIVITY, medicine.medical_treatment, PRETARGETED RADIOIMMUNOTHERAPY, Cancer immunotherapy, Tumor cells, Monoclonal antibody, Epitope, 03 medical and health sciences, Clinical trials, 0302 clinical medicine, Drug Development, Neoplasms, Internal medicine, Antibodies, Bispecific, medicine, Animals, Humans, SINGLE-CHAIN ANTIBODY, Pharmacology (medical), Pretargeted Radioimmunotherapy, BITE ANTIBODY, Pharmacology, Antitumor activity, ANTIGEN-BINDING, biology, business.industry, TARGETED DELIVERY, PHASE-I, 030104 developmental biology, 030220 oncology & carcinogenesis, T-CELLS, biology.protein, Immunotherapy, MONOCLONAL-ANTIBODIES, Antibody, Antibody constructs, business, Signal Transduction

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6fd2d450953eac4bd0cdc5e25edae8fTest
https://doi.org/10.1016/j.pharmthera.2019.04.006Test

المؤلفون: Christiaan van der Leij, Krijn P. van Lienden, Jan J. J. de Vries, Nomdo S Renken, F. Daams, Ronald M. van Dam, C. Yung Nio, M. Liem, Thomas L. Bollen, Geert-Jan Creemers, Steffi J Rombouts, Judith de Vos-Geelen, Gijs A. Patijn, Maartje Los, Sebastiaan Festen, I. Quintus Molenaar, J. Nederend, Derk Jan A. de Groot, Rutger C G Bruijnen, Jan Willem B. de Groot, Joost G Blomjous, Leonie J. M. Mekenkamp, John J. Hermans, Nadia Haj Mohammad, Ignace H. J. T. de Hingh, Susana I S Patuleia, Johanna W. Wilmink, Thijs J Schouten, Maaike E Verweij, Lilly J H Brada, Hjalmar C. van Santvoort, Emile D. Kerver, Vincent E de Meijer, J.F.M. Pruijt, Annelie Vulink, Koop Bosscha, Frank J. Wessels, Maarten S. van Leeuwen, Marc G. Besselink, Marco B. Polee, Olivier R. Busch, Martijn R. Meijerink, M.S. Walma, Martijn W J Stommel

المساهمون: Surgery, RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9), MUMC+: DA BV Medisch Specialisten Radiologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and nuclear medicine, CCA - Cancer biology and immunology, Ophthalmology, Internal medicine, VU University medical center, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and Nuclear Medicine, Oncology, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: European Journal of Surgical Oncology, 47(3), 699-707. ELSEVIER SCI LTD
European Journal of Surgical Oncology, 47(3), 699-707. W.B. Saunders Ltd
for the Dutch Pancreatic Cancer Group 2021, ' Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer : A multicenter prospective cohort ', European Journal of Surgical Oncology, vol. 47, no. 3, pp. 699-707 . https://doi.org/10.1016/j.ejso.2020.11.137Test
European Journal of Surgical Oncology, 47, 699-707
European journal of surgical oncology, 47(3), 699-707. W.B. Saunders Ltd
European Journal of Surgical Oncology, 47, 3, pp. 699-707

مصطلحات موضوعية: Male, Antimetabolites, Antineoplastic, medicine.medical_specialty, Paclitaxel, FOLFIRINOX, medicine.medical_treatment, Locally advanced pancreatic cancer, Leucovorin, Adenocarcinoma, Irinotecan, Deoxycytidine, Cohort Studies, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], All institutes and research themes of the Radboud University Medical Center, Pancreatectomy, Albumins, Internal medicine, Pancreatic cancer, treatment strategies, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Prospective Studies, Prospective cohort study, Response Evaluation Criteria in Solid Tumors, Aged, Chemotherapy, business.industry, General Medicine, Middle Aged, medicine.disease, Gemcitabine, Neoadjuvant Therapy, Oxaliplatin, Pancreatic Neoplasms, Survival Rate, Oncology, Cohort, Treatment strategy, Female, Surgery, Fluorouracil, business, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af8a66a9183508390e581990d356d615Test
https://doi.org/10.1016/j.ejso.2020.11.137Test

المؤلفون: R.M. van Dam, I. H. J. T. de Hingh, V. E. de Meijer, Leonie J. M. Mekenkamp, Johanna W. Wilmink, Derk Jan A. de Groot, Martijn R. Meijerink, N. Haj Mohammad, J.F.M. Pruijt, Koop Bosscha, Gijs A. Patijn, M. Los, Lilly J H Brada, H.C. van Santvoort, G.J.M. Creemers, Marco B. Polee, Sebastiaan Festen, Geert A. Cirkel, J. de Vos-Geelen, Emile D. Kerver, I.Q. Molenaar, M.G. Besselink, M. Liem, J. A. Ropela, M.S. Walma, J.W.B. de Groot, Martijn W J Stommel

المساهمون: Surgery, RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Epidemiologie, Graduate School, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and nuclear medicine, CCA - Cancer Treatment and quality of life, Internal medicine, VU University medical center, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: for the Dutch Pancreatic Cancer Group 2021, ' The treatment and survival of elderly patients with locally advanced pancreatic cancer : A post-hoc analysis of a multicenter registry ', Pancreatology, vol. 21, no. 1, pp. 163-169 . https://doi.org/10.1016/j.pan.2020.11.012Test
Pancreatology, 21, 163-169
Pancreatology, 21(1), 163-169. Elsevier
Pancreatology, 21, 1, pp. 163-169
Pancreatology, 21(1), 163-169. S. Karger AG
Pancreatology, 21(1), 163-169. ELSEVIER SCIENCE BV

مصطلحات موضوعية: Male, FOLFIRINOX, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Locally advanced pancreatic cancer, Kaplan-Meier Estimate, urologic and male genital diseases, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 0302 clinical medicine, Elderly, DISPARITIES, Registries, NAB-PACLITAXEL, Aged, 80 and over, OUTCOMES, Incidence (epidemiology), Age Factors, Gastroenterology, Chemoradiotherapy, Induction Chemotherapy, Middle Aged, CHEMOTHERAPY, 030220 oncology & carcinogenesis, Adenocarcinoma, Female, 030211 gastroenterology & hepatology, Best supportive care, medicine.drug, Adult, medicine.medical_specialty, Young Adult, 03 medical and health sciences, AGE, Drug Therapy, Internal medicine, Pancreatic cancer, Post-hoc analysis, medicine, Humans, Aged, Chemotherapy, Hepatology, OLDER PATIENTS, business.industry, ADENOCARCINOMA, medicine.disease, Survival Analysis, Comorbidity, Gemcitabine, Pancreatic Neoplasms, GEMCITABINE, business, COMORBIDITY

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5414ed7d7980dab4a07cdbd070c10f3dTest
https://research.vumc.nl/en/publications/01ec0bf4-0c27-4e80-99e6-7fc4c055e18fTest

المؤلفون: Mathieu D'Hondt, Sebastiaan Festen, Rutger C G Bruijnen, O.M. van Delden, E. M. van der Waal, I.H.J.T. de Hingh, J. A. Ropela, J. de Vos-Geelen, Johanna W. Wilmink, Chung Y. Nio, R.M. van Dam, Derk Jan A. de Groot, Geert Roeyen, J.W.B. de Groot, K.P. van Lienden, N. Haj Mohammad, S. J. Rombouts, O.R.C. Busch, Lilly J H Brada, G.J.M. Creemers, M. Liem, Gijs A. Patijn, J. de Vries, F. Daams, I.Q. Molenaar, V. E. de Meijer, M. S. van Leeuwen, Maartje Los, Leonie J. M. Mekenkamp, M.S. Walma, I. Oulad Abdennabi, P. Ghorbani, Martijn W J Stommel, H.C. van Santvoort, Elizabeth Pando, Emile D. Kerver, I. H. M. Borel Rinkes, J.F.M. Pruijt, R. van Hillegersberg, Koop Bosscha, Frank J. Wessels, Martijn R. Meijerink, Marc G. Besselink, Marco B. Polee

المساهمون: Dutch Pancreatic Cancer Group, Surgery, CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and nuclear medicine, Internal medicine, MUMC+: MA Heelkunde (9), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Institut Català de la Salut, [Walma MS, Rombouts SJ, Brada LJH] Departments of Surgery, Radiology and Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Departments of Surgery, Radiology and Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. [Borel Rinkes IH, Bruijnen RC] Departments of Surgery, Radiology and Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. [Bosscha K] Departments of Surgery and Medical Oncology, Jeroen Bosch Hospital, ‘s-Hertogenbosch, The Netherlands. [Pando E] Servei de Cirurgia Hepatobiliopancreàtica i Trasplantaments, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, CCA - Cancer Treatment and Quality of Life, Radiology and Nuclear Medicine, Amsterdam Cardiovascular Sciences, Cancer Center Amsterdam, Laboratory for General Clinical Chemistry, Oncology

المصدر: Trials, 22, 1
Trials
Trials, 22
Trials, 22(1):313. BioMed Central
Dutch Pancreatic Cancer Group 2021, ' Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial ', Trials, vol. 22, no. 1, 313 . https://doi.org/10.1186/s13063-021-05248-yTest
Trials, 22(1):313. BioMed Central Ltd
TRIALS, 22(1):313, 1-12. BMC
Scientia
Trials, Vol 22, Iss 1, Pp 1-12 (2021)

مصطلحات موضوعية: Oncology, Medicine (General), Radiofrequency ablation, FOLFIRINOX, SURGERY, medicine.medical_treatment, Locally advanced pancreatic cancer, INTERNATIONAL STUDY-GROUP, Medicine (miscellaneous), 030230 surgery, law.invention, Study Protocol, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Quimioteràpia, Clinical endpoint, Multicenter Studies as Topic, Pharmacology (medical), Overall survival, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias pancreáticas [ENFERMEDADES], Otros calificadores::/terapia [Otros calificadores], Netherlands, Randomized Controlled Trials as Topic, terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Extirpació (Cirurgia), TUMORS, Progression-Free Survival, 030220 oncology & carcinogenesis, SURVIVAL, terapéutica::tratamiento de radiofrecuencia::ablación por radiofrecuencia [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], medicine.drug, medicine.medical_specialty, CLINICAL-OUTCOMES, Therapeutics::Radiofrequency Therapy::Radiofrequency Ablation [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], 03 medical and health sciences, R5-920, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Internal medicine, Pancreatic cancer, Pàncrees - Càncer - Tractament, medicine, Humans, Chemotherapy, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Pancreatic Neoplasms [DISEASES], business.industry, Cancer, ADENOCARCINOMA, Other subheadings::/therapy [Other subheadings], medicine.disease, PHASE-III, Gemcitabine, Pancreatic Neoplasms, DEFINITION, GEMCITABINE, Human medicine, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3471da294f3f1dbd689adeaf8e6be22Test
https://repository.ubn.ru.nl/handle/2066/239066Test

المؤلفون: Urania Dafni, Nathan I. Cherny, Nicola Jane Latino, Jean-Yves Douillard, Daan G Knapen, Panagiota Zygoura, Derk Jan A. de Groot, Elisabeth G.E. de Vries

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: ESMO Open, 5(5):e000681. BMJ PUBLISHING GROUP
ESMO Open
ESMO Open, Vol 5, Iss 5 (2020)

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Colorectal cancer, medicine.medical_treatment, ESMO-MCBS, Medical Oncology, lcsh:RC254-282, Late toxicity, Food and drug administration, Internal medicine, medicine, Humans, Grading (education), Original Research, Chemotherapy, business.industry, United States Food and Drug Administration, toxicity, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, United States, Oxaliplatin, early colon cancer, Clinical trial, adjuvant chemotherapy, quality of life, Colonic Neoplasms, Fluorouracil, business, Adjuvant, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de6f6194e19c0509ba4207adf58f364cTest
https://research.rug.nl/en/publications/590c3cf2-ea12-4d66-97aa-86eb8642fce9Test

المؤلفون: Esmée A Dijkstra, Derk Jan A. de Groot, Denise E. Hilling, Maxime J M van der Valk, Mathijs P. Hendriks, Annet G H Roodvoets, Cornelis J.H. van de Velde, Geke A. P. Hospers, Andrés Cervantes, Albert J. ten Tije, Tone Fokstuen, Hein Putter, Boudewijn van Etten, Elma Meershoek-Klein Kranenbarg, Jaume Capdevila, Bengt Glimelius, Per Nilsson, Renu R. Bahadoer, Corrie A.M. Marijnen, Ibrahim Edhemovic

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: Radiotherapy and Oncology, 147, 75-83. ELSEVIER IRELAND LTD
Radiotherapy & Oncology, 147, 75-83. ELSEVIER IRELAND LTD
RADIOTHERAPY AND ONCOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

مصطلحات موضوعية: medicine.medical_specialty, Colorectal cancer, medicine.medical_treatment, 030218 nuclear medicine & medical imaging, Capecitabine, 03 medical and health sciences, 0302 clinical medicine, Clinical endpoint, Medicine, Chemotherapy, Radiology, Nuclear Medicine and imaging, Rectal cancer, business.industry, Hematology, medicine.disease, Total mesorectal excision, Multimodal treatment, Surgery, Radiation therapy, Oncology, Tolerability, 030220 oncology & carcinogenesis, Concomitant, business, Preoperative radiotherapy, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39372ab0869440ad868733ef6540ce9cTest
https://research.rug.nl/en/publications/2320afdd-177f-486a-986a-d9c863a22426Test

المؤلفون: J.Th.M. Plukker, M de Klerk, Geke A. P. Hospers, E. C. de Heer, Jan Binne Hulshoff, Derk Jan A. de Groot, Johannes G. M. Burgerhof

المساهمون: Life Course Epidemiology (LCE), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: Annals of Surgical Oncology, 24(7), 1811-1820. SPRINGER
Annals of Surgical Oncology

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Esophageal Neoplasms, medicine.medical_treatment, Adenocarcinoma, 030204 cardiovascular system & hematology, PACLITAXEL, THERAPY, 03 medical and health sciences, CHEMORADIATION, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Neoplasm Invasiveness, Prospective Studies, Prospective cohort study, Survival rate, Neoadjuvant therapy, Aged, Retrospective Studies, CARBOPLATIN, Gastrointestinal Oncology, business.industry, Retrospective cohort study, Common Terminology Criteria for Adverse Events, Chemoradiotherapy, Middle Aged, Esophageal cancer, Prognosis, medicine.disease, Combined Modality Therapy, Neoadjuvant Therapy, Esophagectomy, Survival Rate, Lymphatic Metastasis, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Female, Surgery, business, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20aa53e59f8593420ed334952b3dd016Test
https://hdl.handle.net/11370/0d2d3d54-0d60-49be-9eda-653c2ab7a62dTest